Bernd Grabensee

Author PubWeight™ 40.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant 2010 2.35
2 Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis 2002 1.62
3 Biocompatibility of a bicarbonate/lactate-buffered PD fluid tested with a double-chamber cell culture system. Perit Dial Int 2005 1.39
4 A cell-based approach to the minimization of immunosuppression in renal transplantation. Transpl Int 2008 1.24
5 Amyloidosis and bleeding: pathophysiology, diagnosis, and therapy. Am J Kidney Dis 2006 1.24
6 Surgical treatment of renal artery dissection in 25 patients: indications and results. J Vasc Surg 2003 1.11
7 Management of arterial stenosis affecting kidney graft perfusion: a single-centre study in 53 patients. Am J Transplant 2005 1.09
8 Cyclosporine a and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation. Endocrinology 2002 1.01
9 Kidney transplantation from related and unrelated living donors in a single German centre. Nephrol Dial Transplant 2003 0.96
10 Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration. Am J Kidney Dis 2006 0.93
11 Iliac artery stenosis proximal to a kidney transplant: clinical findings, duplex-sonographic criteria, treatment, and outcome. Transplantation 2003 0.93
12 Peritoneal fluid and solute transport: influence of treatment time, peritoneal dialysis modality, and peritonitis incidence. J Am Soc Nephrol 2002 0.92
13 Risk factors for delayed graft function after renal transplantation and their significance for long-term clinical outcome. Transpl Int 2002 0.90
14 Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis. Am J Kidney Dis 2004 0.90
15 Selective cyclooxygenase-2 inhibition upregulates renal cortical alpha V integrin expression. Nephron Exp Nephrol 2003 0.89
16 Dialysis with icodextrin interferes with measurement of serum alpha-amylase activity. Nephrol Dial Transplant 2002 0.87
17 Opportunistic infections after renal transplantation. Curr Opin Urol 2002 0.85
18 Tumor necrosis factor-alpha gene G-308A polymorphism is a risk factor for the development of membranous glomerulonephritis. Am J Nephrol 2006 0.84
19 Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients. Nephrol Dial Transplant 2009 0.84
20 Association of interleukin-10 gene G-1082A polymorphism with the progression of primary glomerulonephritis. Kidney Int 2004 0.83
21 Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study. Nephrol Dial Transplant 2004 0.83
22 Histochemical distribution and expression of aquaporin 1 in the peritoneum of patients undergoing peritoneal dialysis: relation to peritoneal transport. Am J Kidney Dis 2004 0.81
23 Value of diabetes as an independent predictor of death in subjects with end-stage renal disease. Med Klin (Munich) 2006 0.81
24 Fibrillary glomerulonephritis associated with crescents as a therapeutic challenge. Am J Kidney Dis 2002 0.81
25 Association of genotypes of thrombin-activatable fibrinolysis inhibitors with thrombotic microangiopathies--a pilot study. Nephrol Dial Transplant 2007 0.81
26 Tandem plasmapheresis and haemodialysis as a safe procedure in 82 patients with immune-mediated disease. Nephrol Dial Transplant 2008 0.80
27 Prostacyclin enhances the expression of LPS/INF-gamma-induced nitric oxide synthase in human monocytes. Nephron 2002 0.79
28 Indicators of acute and persistent renal damage in adult thrombotic microangiopathy. PLoS One 2012 0.79
29 Critical limb ischaemia as a main cause of death in patients with end-stage renal disease: a single-centre study. Nephrol Dial Transplant 2004 0.79
30 Influence of cytokine genes polymorphisms on long-term outcome in renal transplantation. Clin Transplant 2007 0.79
31 Effluent CA 125 concentration in chronic peritoneal dialysis patients: influence of PD duration, peritoneal transport and PD regimen. Kidney Blood Press Res 2003 0.78
32 Mycophenolic acid inhibits the autocrine PDGF-B synthesis and PDGF-BB-induced mRNA expression of Egr-1 in rat mesangial cells. Nephrol Dial Transplant 2008 0.78
33 Prevalence and risk factors of pre-diabetes after renal transplantation: a single-centre cohort study in 200 consecutive patients. Nephrol Dial Transplant 2012 0.78
34 The TT genotype of the C677T polymorphism in the methylentetrahydrofolate reductase as a risk factor in thrombotic microangiopathies: results from a pilot study. Clin Appl Thromb Hemost 2009 0.78
35 Early conversion from cyclosporine to tacrolimus increases renal graft function in chronic allograft nephropathy at BANFF stages I and II. Transpl Int 2008 0.78
36 Influence of cytokine gene polymorphisms on IgA nephropathy. Ren Fail 2008 0.78
37 Influence of beta3 integrin gene Leu/Pro33 polymorphism on primary glomerulonephritis. Nephron Exp Nephrol 2004 0.78
38 Duplex ultrasound and renin ratio predict treatment failure after revascularization for renal artery stenosis. Am J Hypertens 2006 0.77
39 Influence of interleukin-10 gene G-1082A polymorphism on recurrent IgA nephropathy. J Nephrol 2008 0.77
40 Post-transplant distal limb syndrome: clinical diagnosis and long-term outcome in 37 renal transplant recipients. Transpl Int 2008 0.77
41 Different effect of cyclosporine A and mycophenolate mofetil on passive Heymann nephritis in the rat. Nephron Exp Nephrol 2005 0.77
42 Kidney transplantation in the elderly: age-matching as compared to HLA-matching: a single center experience. Transplantation 2002 0.77
43 Influence of cytokine gene polymorphisms on focal segmental glomerulosclerosis. Am J Nephrol 2004 0.76
44 Cerivastatin inhibits proliferation of interleukin-1 beta-induced rat mesangial cells by enhanced formation of nitric oxide. Eur J Pharmacol 2004 0.76
45 The homozygous leu variant of the factor XIII Val34Leu polymorphism as a risk factor for the manifestation of thrombotic microangiopathies. Clin Appl Thromb Hemost 2007 0.75
46 The G1691A mutation of the factor V gene (factor V Leiden) and the G20210A mutation of the prothrombin gene as risk factors in thrombotic microangiopathies. Clin Appl Thromb Hemost 2009 0.75
47 No evidence for an association of AB0 blood group and manifestation of thrombotic microangiopathies. Int J Cardiol 2011 0.75
48 Acute pain over the kidney graft and Duplex-sonographic findings mimicking complete renal transplant vein thrombosis. Nephrol Dial Transplant 2002 0.75
49 [Diagnosis, treatment, and prognosis of renal artery stenosis]. Med Klin (Munich) 2006 0.75
50 Are prothrombotic variants of platelet glycoprotein receptor polymorphisms involved in the pathogenesis of thrombotic microangiopathies? Clin Appl Thromb Hemost 2008 0.75
51 Hodgkin disease-like posttransplantation lymphoproliferative disorder of donor origin in a renal allograft recipient. Am J Kidney Dis 2006 0.75
52 [Arteriosclerotic renal artery stenosis. Significance, diagnosis and therapy options]. Med Klin (Munich) 2002 0.75
53 High clotting factor activities and enhanced platelet-related haemostasis in a patient with recurrent episodes of thrombotic-thrombocytopenic purpura: additional risk factors for onset and recurrence? Nephrol Dial Transplant 2005 0.75
54 Effects of candesartan on glomerular hemodynamics and permselectivity in patients with favorable renal allograft function. Transplantation 2005 0.75